Overview
- Shares debuted at Rs 491.70 on the BSE and Rs 490 on the NSE, a 6.9% and 6.5% premium respectively to the Rs 460 issue price.
- The stock later closed near Rs 471 on both exchanges, leaving first-day gains at about 2.5% over the issue price.
- The offering drew 13.96 times overall subscription, led by QIBs at 27.47 times and NIIs at 24.27 times, with retail at 2.31 times.
- Fresh-issue proceeds are designated for Rs 136 crore in debt repayment and Rs 129 crore of capex to open new dialysis clinics in India.
- Pre-listing grey-market quotes of roughly Rs 35–37 per share implied a higher pop, though such indications are unofficial and speculative.